CFTR and amyloidosis: Accurate assessment of renal function is a prerequisite for the proper management of patients with CF at increased risk of renal failure due to CFTR genetics, amyloidosis, repeated treatment with aminoglycosides (associated with salt loss), fluid imbalance, diabetes, malnutrition, hypoxia and other clinical conditions.